Literature DB >> 3487010

Medical and psychiatric determinants of outpatient medical utilization.

A J Barsky, G Wyshak, G L Klerman.   

Abstract

Ninety-two general medical outpatients were surveyed with an interview, questionnaires, and a medical record review to investigate the relationships among psychiatric disorder (depression and hypochondriasis), somatic symptoms, medical morbidity, and the utilization of ambulatory medical services. Medical utilization correlated with the number of somatic symptoms reported (r = 0.49, P = 0.0001), depressive symptoms (r = 0.34, P = 0.001), and the number of medical diagnoses in the medical record. Somatic symptoms were not significantly correlated with the number of medical diagnoses, but were related to hypochondriacal attitudes (r = 0.52, P = 0.0001) and depression (r = 0.51, P = 0.0001). In stepwise multiple regressions, the number of medical diagnoses accounted for 33% of the variance in medical utilization. Somatic symptoms were the second most powerful predictor, increasing R2 to 0.469. The next best predictors were two hypochondriacal attitudes and the presence of a major psychiatric diagnosis in the medical record. This five-step model explained 56% of the variance. Somatic symptoms are thus powerful determinants of medical utilization, even after controlling for medical morbidity. Depression, disease fear, and bodily preoccupation are also important predictors of utilization. Somatic symptoms are a final common pathway through which emotional disturbance, psychiatric disorder, and organ pathology all express themselves, and which prompt patients to visit doctors.

Entities:  

Mesh:

Year:  1986        PMID: 3487010     DOI: 10.1097/00005650-198606000-00009

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  15 in total

1.  Substance abuse as a predictor of VA medical care utilization among Vietnam veterans.

Authors:  K S Virgo; R K Price; E L Spitznagel; T H Ji
Journal:  J Behav Health Serv Res       Date:  1999-05       Impact factor: 1.505

2.  The process and outcome of life review psychotherapy with depressed homebound older adults.

Authors:  G J McDougall; C E Buxen; L J Suen
Journal:  Nurs Res       Date:  1997 Sep-Oct       Impact factor: 2.381

3.  Noncompliance in end-stage renal disease: A threat to quality of care and cost containment.

Authors:  A L Brickman; S E Yount
Journal:  J Clin Psychol Med Settings       Date:  1996-12

4.  Use of psychiatric services by patients in a general hospital.

Authors:  R Mayou; V Seagroatt; M Goldacre
Journal:  BMJ       Date:  1991-10-26

5.  Psychopathology as a predictor of medical service utilization for youth in residential treatment.

Authors:  Timothy D Nelson; Tori R Smith; Robert Pick; Michael H Epstein; Ronald W Thompson; Thomas F Tonniges
Journal:  J Behav Health Serv Res       Date:  2013-01       Impact factor: 1.505

6.  Sources of somatization: exploring the roles of insecurity in relationships and styles of anger experience and expression.

Authors:  Liang Liu; Shiri Cohen; Marc S Schulz; Robert J Waldinger
Journal:  Soc Sci Med       Date:  2011-08-31       Impact factor: 4.634

7.  Screening for undetected mental disorders in high utilizers of primary care services.

Authors:  F Lefevre; D Reifler; P Lee; M Sbenghe; N Nwadiaro; S Verma; P R Yarnold
Journal:  J Gen Intern Med       Date:  1999-07       Impact factor: 5.128

8.  A randomized trial of treatments for high-utilizing somatizing patients.

Authors:  Arthur J Barsky; David K Ahern; Mark R Bauer; Nyryan Nolido; E John Orav
Journal:  J Gen Intern Med       Date:  2013-03-14       Impact factor: 5.128

9.  Sleep problems and their correlates in a working population.

Authors:  M Kuppermann; D P Lubeck; P D Mazonson; D L Patrick; A L Stewart; D P Buesching; S K Fifer
Journal:  J Gen Intern Med       Date:  1995-01       Impact factor: 5.128

10.  Somatization: a borderland between medicine and psychiatry.

Authors:  Z J Lipowski
Journal:  CMAJ       Date:  1986-09-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.